Effects of Light Intensity Physical Activities on Pre-frontal Cortical Activation, Cognitive Function, Sleepiness and Back Pain

April 13, 2026 updated by: Chia Yong Hwa Michael

Investigating the Acute Effects of Light Intensity Physical Activities on Pre-frontal Cortical Activation, Cognitive Function, Sleepiness and Back Pain Among Physically Inactive University Students

The objective of this randomised controlled trial is to examine the acute effects of two novel light intensity exercise (sit-cycling and stand-twisting) on prefrontal cortical blood oxygenation, executive functioning, sleepiness and back pain among inactive university students.

The main questions it aims to answer are:

  • What are the changes in oxygenated haemoglobin (O2Hb) and deoxygenated hemoglobin (HHb) levels in the prefrontal cortex from baseline to immediately after and 20 minutes after a 5-min bout of S-C and S-T compared to sitting for the same duration?
  • What are the changes in executive functioning, specifically, n-back test and Word Colour Stroop test performance from baseline to immediately after and 20 minutes after a bout of S-C and S-T compared to sitting for the same duration?
  • How does participants' self-rated daytime sleepiness and back pain after a bout of S-C and S-T compare to sitting for the same duration?

Participants will:

  • Perform sit-cycling or stand-twisting for 5 mins (experimental condition) and sit for 5 mins (control condition)
  • Wear the functional near-infrared spectroscopy cap on their head throughout the measurements
  • Complete 1-back, 2-back test and Word Colour Stroop before, immediately after and 20 minutes after experimental/ control condition
  • Have their blood pressure, heart rate taken by a smartwatch
  • Complete a daytime sleepiness questionnaire and a back pain questionnaire

Study Overview

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Singapore
      • Singapore, Singapore, Singapore
        • Block 5 Physical Education and Sport Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • NTU-NIE university student, between 21 and 30 years old, do not meet physical activity guidelines (150 mins of weekly MVPA)

Exclusion Criteria:

  • taking blood-pressure lowering medication
  • physically active (150 mins or more of weekly MVPA)
  • deemed not physically fit to participate in physical activity based on responses to Get Active Questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sit-cycling
Sit-cycling on a seat-cycle for 5 mins
Sit-cycling for 5 mins
Experimental: Stand-twisting
Stand-twisting on a stand-twister for 5 mins
Stand-twisting for 5 mins
No Intervention: Sitting only
Sitting only for 5 mins

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
1-back test accuracy (%)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Number of correct trials (correct recall)
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
1-back test reaction time (ms)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Average reaction time across trials
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
2-back test accuracy (%)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Number of correct trials (correct recall)
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
2-back test reaction time (ms)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Average reaction time across trials
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Colour Word Stroop test accuracy (congruent) (%)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Number of correct trials recall
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Colour Word Stroop test accuracy (incongruent) (%)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Number of correct trials recall
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Colour Word Stroop test reaction time (congruent) (ms)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Average reaction time across trials
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Colour Word Stroop test reaction time (incongruent) (ms)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
Average reaction time across trials
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
pre-frontal cortical oxygenated hemoglobin levels (micrometre)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
measured by functional near infrared spectroscopy
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
pre-frontal cortical deoxygenated hemoglobin levels (micrometre)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
measured by functional near infrared spectroscopy
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 11, 2024

Primary Completion (Actual)

December 31, 2024

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

November 21, 2024

First Submitted That Met QC Criteria

November 21, 2024

First Posted (Actual)

November 25, 2024

Study Record Updates

Last Update Posted (Actual)

April 16, 2026

Last Update Submitted That Met QC Criteria

April 13, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data constitute as personal data. Under the Singapore Personal Data Protection Act, it is mandatory that individually identifiable data are to be kept confidential.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sit-cycling

Subscribe